GI
GSK icon

GAMMA Investing’s GSK GSK Stock Holding History

GAMMA Investing’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Buy
11,330
+840
+8% +$44.4K 0.02% 575
2026
Q1 		$579K Buy
10,490
+792
+8% +$42.9K 0.03% 516
2025
Q4 		$476K Buy
9,698
+1,586
+20% +$74K 0.02% 547
2025
Q3 		$350K Buy
8,112
+1,959
+32% +$76.5K 0.02% 641
2025
Q2 		$236K Buy
6,153
+1,706
+38% +$65.2K 0.01% 807
2025
Q1 		$172K Buy
4,447
+2,307
+108% +$84.5K 0.01% 858
2024
Q4 		$72.4K Sell
2,140
-1,161
-35% -$41.8K 0.01% 1357
2024
Q3 		$135K Sell
3,301
-105
-3% -$4.29K 0.01% 812
2024
Q2 		$131K Sell
3,406
-223
-6% -$9.38K 0.02% 651
2024
Q1 		$156K Buy
3,629
+874
+32% +$36K 0.03% 475
2023
Q4 		$109K Buy
+2,755
New +$98.9K 0.03% 511

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

GAMMA Investing's GSK Position: Q2 2026 in Review

GAMMA Investing increased its GSK (GSK) stake by 8% in Q2 2026, buying an estimated $44.4K and bringing the position to 11,330 shares worth $594K. The position accounts for 0.02% of the portfolio, ranked #575.

GAMMA Investing first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. 186 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • GAMMA Investing held 11,330 shares of GSK worth $594K as of Q2 2026.
  • GAMMA Investing bought 840 GSK shares in Q2 2026, an estimated $44.4K.
  • GSK made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #575 holding.
  • GAMMA Investing first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • 186 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.